LIM-0705

N/A

Report date: 2022/11/25 17:58:24
NME

Base Information

Drug NameLIM-0705
Drug Alias NameLIM-0705
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP binding cassette subfamily A member 1 stimulants
TargetsATP binding cassette subfamily A member 1
Therapy Area/IndicationsInsulin ResistanceGlucose Intolerance
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLimerick
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLimerick Biopharma Inc
Active IndicationsN/A
Inactive IndicationsInsulin ResistanceGlucose Intolerance

Other Information

ATC CodeN/A
Related LinksN/A